http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4438138-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ede6dfd510f800f051b3578956a2999
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C225-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 1982-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1984-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caf8e2dacdfe3b412011480a034241e2
publicationDate 1984-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4438138-A
titleOfInvention Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
abstract A method of treatment for reducing cholesterol in humans by the administration of the compound of the formula I ##STR1## or a pharmaceutically acceptable acid addition salt thereof in a non-toxic, effective therapeutic amount (calculated as base) to a human in need thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010278926-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6893660-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7771750-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003022942-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6855820-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5358970-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-762624-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8501227-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6734213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6369113-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004101556-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010125070-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005096318-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003198683-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6905708-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5541231-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6337328-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5427798-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003064988-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6495605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006189612-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8747898-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5763493-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8545880-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002052340-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6277887-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0033827-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6451860-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006058300-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003161874-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1602369-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003032643-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005085551-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6110973-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6458374-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005147678-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7098206-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6342496-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6998400-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5731000-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005142195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6512011-B1
priorityDate 1982-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129262404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424248

Total number of triples: 60.